Trial Profile
Dose-Proportionality and Intra-Individual Variability of Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate In Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B; HIV infections
- Focus Pharmacokinetics
- Acronyms HPTN066
- 16 Nov 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 16 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2011 Planned End Date changed from 1 Jun 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.